Compete - Line of Research


What role do the state of technological innovation and competitiveness in the United States have in national power? We offer recommendations for research and development policy, science and technology strategy, and research security. We also weigh in on the use of investments and incentives to strengthen the innovation ecosystem; export controls, sanctions and related policies to protect intellectual property and sensitive technologies; and trade rules and antitrust approaches to promote a fair and vibrant competitive environment. 

Recent Publications


China, Biotechnology, and BGI

Anna Puglisi Chryssa Rask
| May 2024

As the U.S. government considers banning genomics companies from China, it opens a broader question about how the United States and other market economies should deal with China’s “national champions.” This paper provides an overview of one such company—BGI—and how China’s industrial policy impacts technology development in China and around...

Read More

Formal Response

Comment on BIS Request for Information

Jacob Feldgoise Hanna Dohmen
| April 30, 2024

Jacob Feldgoise and Hanna Dohmen at the Center for Security and Emerging Technology (CSET) at Georgetown University offer the following response to the Bureau of Industry and Security’s (BIS) Notice of Proposed Rulemaking (NPRM): Taking Additional Steps To Address the National Emergency With Respect to Significant Malicious Cyber-Enabled Activities (89...

Read More

CSET's Ngor Luong testified before the U.S.-China Economic and Security Review Commission where she discussed Chinese investments in military applications of AI.

Read More

Recent Blog Articles

China Bets Big on Military AI

Sam Bresnick
| April 3, 2024

In his op-ed published by the Center for European Policy Analysis (CEPA), CSET’s Sam Bresnick shared his expert analysis on China's evolving military capabilities and its growing emphasis on battlefield information and the role of AI.

Read More

China’s Hybrid Economy: What to Do about BGI?

Anna Puglisi
| February 2, 2024

As the U.S. government considers banning genomics companies from China in the Biosecure Act, it opens a broader question of how the U.S. and other market economies should deal with China’s national champions. This blog post provides an overview of BGI and how China’s industrial policy impacts technology development.

Read More

RISC-V: What it is and Why it Matters

Jacob Feldgoise
| January 22, 2024

As the U.S. government tightens its controls on China’s semiconductor ecosystem, a new dimension is increasingly worrying Congress: the open-source chip architecture known as RISC-V (pronounced “risk-five”). This blog post provides an introduction to the RISC-V architecture and an explanation of what policy-makers can do to address concerns about this...

Read More

Our People

Hanna Dohmen

Research Analyst

Jack Corrigan

Senior Research Analyst

Jacob Feldgoise

Data Research Analyst

Ngor Luong

Senior Research Analyst

Related News

In an article published by The Wall Street Journal that delves into the changing economic dynamics between the U.S. and China, CSET's Ngor Luong provides her expert insight.
A CSET report written by Emily S. Weinstein and Ngor Luong was cited in an article by Foreign Policy. The article delves into Joe Biden's recent executive order to initiate restrictions on U.S. investment in three specific technology sectors in China: semiconductors, quantum information technologies, and artificial intelligence (AI).
In The News

China Deepfake Regulations

January 10, 2023
In an interview with BBC World News, Research Analyst Hanna Dohmen explains the significance of China's new regulations on deepfake technology.